The content on this site is intended for healthcare professionals only
This module explores current research on biosimilars used in cancer treatment covering biosimilars and their forms, clinical standards and guidelines and the process of interchangeability and switching.
Published October 2018.
This resource is aimed mainly for physicians and pharmacists but extends to those who wish to know about biosimilars and how it can be used for cancer treatment.
By the end of this module, the learner should be able to:
This module requires the learner to have a good, stable internet connection and can run on Internet Explorer 7 and above, Mozilla Firefox, Google Chrome and Opera on either Windows or MacOS. Flash Add-on is also required to run this module.
If you are viewing this module on an iPad (through a browser), please download the free Articulate Mobile Player beforehand. Other tablet devices may not be compatible - please check for Flash compatibility.
If you are experiencing technical difficulties, please contact education@ecancer.org and we will get back to you as soon as possible.
ecancer and everyone involved in the development of this module has no actual or potential conflict of interest whatsoever which impinges on the making, peer reviewing and dissemination of this e-learning module which was made possible through an unrestricted educational grant from Amgen.
Production of this module was funded by an unrestricted grant from Amgen.
